Drugs affecting the gastrointestinal system

Docusate sodium salt is an anionic surfactant. Application Docusate sodium salt has been used in a study to assess chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.

Docusate sodium salt is an anionic surfactant. Application Docusate sodium salt has been used in a study to assess chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.

Docusate sodium salt is an anionic surfactant. Application Docusate sodium salt has been used in a study to assess chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Cell Line Origin Rat pancreatic carcinoma Cell Line Description DSL6A/C1 were derived from a transplantable acinar cell carcinoma (DSL-6) that had been established from a primary carcinoma of the pancreas in an azaserine treated Lewis rat. The

With easy-to-read scale and large labeling field for easy marking in fired-on, highly durable ceramic ink. Complete system including DURAN&reg Pressure plus laboratory bottle with 4-port screw cap (PP) , four screw connectors (black, M* thread) and

A cell-permeable semicarbazone compound that inhibits the GTPase activity of dynamin1/2 (IC 50 ~15 &#181M) and Drp1, while exhibiting no significant effect against two other small GTPases, MxA and Cdc42. Dynasore has been used to elucidate the

A highly potent (IC 50 = 0.38 and 2.

A cell-permeable, allosteric Dynamin inhibitor (IC 50 = 6.9 &#181M and 14 &#181M for full length Dynamin I and Dynamin II GTPase activity, respectively, in vitro ).

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the